期刊文献+

卵巢恶性肿瘤脾转移12例临床分析 被引量:3

Intrasplenic metastasis of malignant ovariantumor: clinical analysis of 12 cases
原文传递
导出
摘要 我院自1986~1992年共诊断卵巢恶性肿瘤脾转移12例,占同期收治卵巢恶性肿瘤的1.2%。其中,低分化者占50%。通过影像学与手术进行诊断,发现脾转移距发现原发灶的中位发生时间为28个月。形态特点为脾实质内单发或多发结节。临床表现无明显特异性。发生原因可能为肿瘤体积大、分化差、化疗致宿主免疫力低下等。脾转移多在肝转移之后或同时出现。转移途径可能以血行转移为主。单纯脾转移行手术切除,可望得到较好疗效。脾转移患者的预后差,死亡率高,中位生存时间为7个月。 ntrasplenic metastasis of ovarian malignancies areuncommon- From 1986 to 1992 only 12 such cases werediagnosed, being 1. 2/00 of the total number of patientswith ovarian malignancies treated in tumor hospital dur-ing the same period. Of the 12 metastasis, 6 were poor-ly differentiated. Diagnosis was made through iniagingtechniques or surgery.The median interval from the di-agnosis of the primary disease to intrasplenic involve-ment was 28 months. The metastatic Lesions, present-ed themselves as single or multiple nodes within the cor-tex of the spleen. Clinical features were not remarkable.It was thought that the occurrence of intrasplenic in-volvement might be due to greater tumor bulk, poor dif-ferentiation and decreased host immuno-competencecaused by chemotherapy. Most of the intrasplenicmetastasis was found after liver metastasis or simultane-ously with the latter. The main route of the tumorspread might be via blood vessels. Sole intrasplenicmetastasis can be treated by surgery with a temporarilygood result. Poor prognosis and high mortality charac-terize intrasplenic metastasis. Themedian survival wasonly 7 months.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 1994年第12期724-726,T081,共4页 Chinese Journal of Obstetrics and Gynecology
关键词 卵巢肿瘤 肿瘤转移 脾转移 临床分析 Ovarian neoplasms SpleenMetastasis
  • 相关文献

同被引文献13

  • 1杨蓉,冯捷,房祥忠,白符,成夜霞,刘晨,朱炜,李林.卵巢浆液性腺癌预后评分模型的建立及应用[J].中华妇产科杂志,2006,41(7):459-463. 被引量:10
  • 2Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal eytoreduetive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol, 2002, 20 : 1248-1259.
  • 3Manci N, Bellati F, Muzii L, et aL Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data. Ann Surg Oncol, 2006,13 : 1717-1723.
  • 4Spencer N J, Spencer JA, Perren TJ, et al. CT appearances and prognostic significance of splenic metastasis in ovarian cancer. Clin Radiol, 1998, 53:417-421.
  • 5Ayhan A, Al RA, Baykal C, et al. The influence of splenic metastases on survival in FIGO stage Ⅲ c epithelial ovarian cancer. Int J Gynecol Cancer, 2004, 14: 51-56.
  • 6Magtibay PM, Adams PB, Silverman MB, et al. Splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol, 2006,102:369-374.
  • 7Nicklin JL, Copeland LJ, O'Toole RV, et al. Splenectomy as part of cytoreductive surgery for ovarian carcinoma. Gynecol Oncol, 1995, 58:244-247.
  • 8Eisenkop SM, Spirtos NM, Lin WC. Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer. Gynecol Oncol, 2006,100:344-348.
  • 9Marymont JH Jr, Gross S. Patterns of metastatic cancer in the spleen. Am J Clin Pathol, 1963,40 : 58-66.
  • 10Berge T. Splenic mecastases. Frequencies and patterns. Acta Pathol Microbiol Scand A, 1974,82:499-506.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部